| Literature DB >> 35126939 |
Yuyan Wang1, Wei Yu2, Jufang Zhang1, Jinsheng Li1.
Abstract
OBJECTIVE: To investigate the effect and safety of PRP and Yifu combined with ultrapulsed CO2 lattice laser in patients with sunken acne scar.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35126939 PMCID: PMC8808142 DOI: 10.1155/2022/6803988
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 2.682
Comparison of the clinical efficacy of the two groups (n (%)).
| Groups |
| Cure | Significant effect | Effective | Invalid | Total effective |
|---|---|---|---|---|---|---|
| Control group | 350 | 47 (13.43) | 82 (23.43) | 116 (33.14) | 105 (30.00) | 245 (70.00) |
| Study group | 350 | 56 (16.00) | 91 (26.00) | 138 (39.43) | 65 (18.57) | 285 (81.43) |
|
| 5.232 | |||||
|
| <0.05 |
Comparison of the improvement of scar between the two groups (, score).
| Groups |
| ECCA | VSS | ||
|---|---|---|---|---|---|
| Before treatment | After treatment | Before treatment | After treatment | ||
| Control group | 350 | 89.12 ± 7.08 | 69.21 ± 3.15 | 8.41 ± 1.14 | 5.65 ± 2.86 |
| Study group | 350 | 89.83 ± 6.98 | 49.38 ± 2.69 | 8.39 ± 1.21 | 3.55 ± 1.72 |
|
| 0.875 | 8.631 | 0.147 | 7.707 | |
|
| >0.05 | <0.05 | >0.05 | <0.05 | |
Note. Compared with before treatment, P < 0.05.
Comparison of the scores of quality of life between the two groups (, score).
| Groups |
| Daily activities | Symptoms and feelings | Work and study | Leisure and entertainment | Interpersonal relationship | Treatment condition | Total score | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |||
| Control group | 350 | 2.23 ± 0.46 | 1.16 ± 0.24 | 2.48 ± 0.22 | 1.73 ± 0.19 | 2.49 ± 0.23 | 1.71 ± 0.18 | 1.64 ± 1.08 | 1.48 ± 0.55 | 2.44 ± 0.33 | 1.58 ± 0.38 | 2.17 ± 0.51 | 1.69 ± 0.46 | 13.27 ± 1.35 | 10.06 ± 0.51 | |
| Study group | 350 | 2.28 ± 0.39 | 0.51 ± 0.13 | 2.51 ± 0.26 | 1.30 ± 0.09 | 2.43 ± 0.19 | 1.08 ± 0.20 | 1.66 ± 1.10 | 0.79 ± 0.24 | 2.45 ± 0.40 | 1.03 ± 0.16 | 2.12 ± 0.49 | 0.59 ± 0.30 | 13.22 ± 1.33 | 8.63 ± 0.34 | |
|
| 1.015 | 29.166 | 1.079 | 25.050 | 2.463 | 28.676 | 0.159 | 14.083 | 0.236 | 16.337 | 0.866 | 24.531 | 0.323 | 28.573 | ||
|
| >0.05 | <0.05 | >0.05 | <0.05 | >0.05 | <0.05 | >0.05 | <0.05 | >0.05 | <0.05 | >0.05 | <0.05 | >0.05 | <0.05 | ||
Note. Compared with before treatment, P < 0.05.
Comparison of the occurrence of adverse reactions between the two groups (n (%)).
| Groups |
| Erythema | Edema | Pigmentation | Total occurrence |
|---|---|---|---|---|---|
| Control group | 350 | 30 (8.57) | 35 (10.00) | 35 (10.00) | 100 (28.57) |
| Study group | 350 | 21 (6.00) | 25 (7.33) | 14 (4.00) | 60 (17.33) |
|
| 5.439 | ||||
|
| <0.05 |